SMAD2 and cancer: Recently, it has been shown that FHL1, FHL2, and FHL3 physically and functionally interact with Smad2, Smad3, and Smad4, important regulators of cancer development and progression, and inhibit human hepatoma cell growth in vitro and in vivo[8].